LiveWire Ergogenics, Inc. Logo

LiveWire Ergogenics, Inc.

LVVV

(1.8)
Stock Price

0,00 USD

7.65% ROA

19.65% ROE

2.95x PER

Market Cap.

1.511.250,00 USD

102.65% DER

0% Yield

55.57% NPM

LiveWire Ergogenics, Inc. Stock Analysis

LiveWire Ergogenics, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

LiveWire Ergogenics, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (577.27%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-0.58x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-70%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

5 ROA

The stock's ROA (-1351.08%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

LiveWire Ergogenics, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

LiveWire Ergogenics, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

LiveWire Ergogenics, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

LiveWire Ergogenics, Inc. Revenue
Year Revenue Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 402.340 100%
2012 148.034 -171.79%
2013 146.169 -1.28%
2014 238.957 38.83%
2015 19.920 -1099.58%
2015 45.130 55.86%
2016 9.071 -397.52%
2017 0 0%
2018 35.709 100%
2019 344.230 89.63%
2020 580.315 40.68%
2021 851.199 31.82%
2022 1.938.030 56.08%
2023 1.633.744 -18.63%
2024 338.872 -382.11%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

LiveWire Ergogenics, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

LiveWire Ergogenics, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 142.478
2008 116.137 -22.68%
2009 42.665 -172.21%
2010 121.358 64.84%
2011 524.162 76.85%
2012 1.605.766 67.36%
2013 869.131 -84.76%
2014 2.827.508 69.26%
2015 292.928 -865.26%
2015 0 0%
2016 0 0%
2017 768.274 100%
2018 7.922.943 90.3%
2019 1.550.885 -410.87%
2020 841.879 -84.22%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

LiveWire Ergogenics, Inc. EBITDA
Year EBITDA Growth
2007 -163.501
2008 -130.836 -24.97%
2009 -52.665 -148.43%
2010 -121.358 56.6%
2011 -386.664 68.61%
2012 -1.664.679 76.77%
2013 -881.232 -88.9%
2014 -2.884.933 69.45%
2015 -288.180 -901.09%
2015 -336.850 14.45%
2016 -17.550 -1819.37%
2017 -768.270 97.72%
2018 -7.947.280 90.33%
2019 -897.640 -785.35%
2020 -301.560 -197.67%
2021 -2.340.790 87.12%
2022 777.900 400.91%
2023 869.360 10.52%
2024 3.040 -28497.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

LiveWire Ergogenics, Inc. Gross Profit
Year Gross Profit Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 143.864 100%
2012 11.017 -1205.84%
2013 52.577 79.05%
2014 -1.661 3265.38%
2015 7.392 122.47%
2015 -4.824 253.23%
2016 1.073 549.58%
2017 0 0%
2018 -142.207 100%
2019 197.025 172.18%
2020 376.506 47.67%
2021 701.553 46.33%
2022 1.804.864 61.13%
2023 1.594.369 -13.2%
2024 313.596 -408.41%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

LiveWire Ergogenics, Inc. Net Profit
Year Net Profit Growth
2007 -152.623
2008 -156.836 2.69%
2009 -32.665 -380.13%
2010 -121.358 73.08%
2011 -392.945 69.12%
2012 -1.702.803 76.92%
2013 -1.265.936 -34.51%
2014 -4.183.518 69.74%
2015 -646.040 -547.56%
2015 -490.344 -31.75%
2016 -78.284 -526.37%
2017 -1.199.385 93.47%
2018 -11.592.864 89.65%
2019 -1.775.629 -552.89%
2020 -1.600.899 -10.91%
2021 -3.432.426 53.36%
2022 684.124 601.73%
2023 921.575 25.77%
2024 165.036 -458.41%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

LiveWire Ergogenics, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

LiveWire Ergogenics, Inc. Free Cashflow
Year Free Cashflow Growth
2007 -61.447
2008 -106.836 42.48%
2009 -28.254 -278.13%
2010 -26.227 -7.73%
2011 -241.718 89.15%
2012 -567.999 57.44%
2013 -500.167 -13.56%
2014 -762.464 34.4%
2015 -66.873 -1040.17%
2015 -148.237 54.89%
2016 -676 -21828.55%
2017 -174.734 99.61%
2018 -1.347.157 87.03%
2019 -790.060 -70.51%
2020 315.334 350.55%
2021 -467.213 167.49%
2022 396.371 217.87%
2023 682.370 41.91%
2024 71.033 -860.64%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

LiveWire Ergogenics, Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 -61.447
2008 -106.836 42.48%
2009 -28.254 -278.13%
2010 -26.227 -7.73%
2011 -238.728 89.01%
2012 -551.299 56.7%
2013 -500.167 -10.22%
2014 -757.463 33.97%
2015 -66.873 -1032.69%
2015 -148.237 54.89%
2016 -676 -21828.55%
2017 -174.734 99.61%
2018 -861.861 79.73%
2019 -778.860 -10.66%
2020 356.156 318.69%
2021 -399.890 189.06%
2022 396.371 200.89%
2023 682.370 41.91%
2024 71.033 -860.64%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

LiveWire Ergogenics, Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 2.990 100%
2012 16.700 82.1%
2013 0 0%
2014 5.001 100%
2015 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 485.296 100%
2019 11.200 -4233%
2020 40.822 72.56%
2021 67.323 39.36%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

LiveWire Ergogenics, Inc. Equity
Year Equity Growth
2007 94.053
2008 -62.783 249.81%
2009 -19.411 -223.44%
2010 -140.769 86.21%
2011 -782.845 82.02%
2012 -891.029 12.14%
2013 -765.479 -16.4%
2014 -683.933 -11.92%
2015 -855.688 20.07%
2015 -911.626 6.14%
2016 -933.972 2.39%
2017 -1.019.738 8.41%
2018 -193.701 -426.45%
2019 219.406 188.28%
2020 -1.077.655 120.36%
2021 912.132 218.15%
2022 2.029.004 55.05%
2023 3.113.731 34.84%
2024 3.262.691 4.57%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

LiveWire Ergogenics, Inc. Assets
Year Assets Growth
2007 94.053
2008 50 -188006%
2009 0 0%
2010 0 0%
2011 106.396 100%
2012 68.947 -54.32%
2013 62.962 -9.51%
2014 309.643 79.67%
2015 162.578 -90.46%
2015 175.965 7.61%
2016 146.116 -20.43%
2017 112.895 -29.43%
2018 1.752.010 93.56%
2019 3.322.956 47.28%
2020 2.908.664 -14.24%
2021 4.520.877 35.66%
2022 6.271.903 27.92%
2023 7.735.532 18.92%
2024 7.976.364 3.02%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

LiveWire Ergogenics, Inc. Liabilities
Year Liabilities Growth
2007 0
2008 62.833 100%
2009 19.411 -223.7%
2010 140.769 86.21%
2011 889.241 84.17%
2012 959.976 7.37%
2013 828.441 -15.88%
2014 993.576 16.62%
2015 1.018.265 2.42%
2015 1.087.591 6.37%
2016 1.080.088 -0.69%
2017 1.132.633 4.64%
2018 1.945.711 41.79%
2019 3.103.550 37.31%
2020 3.986.319 22.14%
2021 3.608.745 -10.46%
2022 4.242.899 14.95%
2023 4.621.801 8.2%
2024 4.713.673 1.95%

LiveWire Ergogenics, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
2.95x
Price To Sales Ratio
1.38x
POCF Ratio
3.24
PFCF Ratio
2.72
Price to Book Ratio
0.55
EV to Sales
4.4
EV Over EBITDA
9.24
EV to Operating CashFlow
8.72
EV to FreeCashFlow
8.72
Earnings Yield
0.34
FreeCashFlow Yield
0.37
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
0
Income Quality
0.91
ROE
0.2
Return On Assets
0.08
Return On Capital Employed
0.15
Net Income per EBT
1
EBT Per Ebit
1.23
Ebit per Revenue
0.45
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.98
Operating Profit Margin
0.45
Pretax Profit Margin
0.56
Net Profit Margin
0.56

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.08
Return on Tangible Assets
0.08
Days Sales Outstanding
2466.54
Days Payables Outstanding
18152.65
Days of Inventory on Hand
0
Receivables Turnover
0.15
Payables Turnover
0.02
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
0
Debt to Equity
1.03
Debt to Assets
0.42
Net Debt to EBITDA
6.35
Current Ratio
1.6
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
2993689
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
2.22

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

LiveWire Ergogenics, Inc. Dividends
Year Dividends Growth

LiveWire Ergogenics, Inc. Profile

About LiveWire Ergogenics, Inc.

LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.

CEO
Mr. William J Hodson
Employee
1
Address
1600 North Kraemer Boulevard
Anaheim, 92806

LiveWire Ergogenics, Inc. Executives & BODs

LiveWire Ergogenics, Inc. Executives & BODs
# Name Age
1 Mr. AJ Moreno
Compliance Manager - Government Liaison
70
2 Mr. William Riley
President
70
3 Mr. William J Hodson
Chief Executive Officer, Chief Accounting Officer, Treasurer & Director
70
4 Mr. Cliff Rusin
Chief Operating Officer
70
5 Mr. Kyle McKay
Master Horticulturist, Member of Scientific Advisory Board and 7Xpure Advisory & Compliance Board
70

LiveWire Ergogenics, Inc. Competitors